Adam L. Burrack

1.7k total citations
14 papers, 597 citations indexed

About

Adam L. Burrack is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Adam L. Burrack has authored 14 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Immunology and 4 papers in Surgery. Recurrent topics in Adam L. Burrack's work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Adam L. Burrack is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Adam L. Burrack collaborates with scholars based in United States, Croatia and Russia. Adam L. Burrack's co-authors include Brian T. Fife, Tijana Martinov, Ingunn M. Stromnes, Ellen J. Spartz, Justin A. Spanier, Iris Wang, Jason S. Mitchell, Kevin C. Osum, Klearchos K. Papas and Christopher Tucker and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Diabetes.

In The Last Decade

Adam L. Burrack

14 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam L. Burrack United States	10	257	223	210	192	135	14	597
Maja Wållberg United Kingdom	11	182 0.7×	195 0.9×	42 0.2×	134 0.7×	84 0.6×	18	405
Jingbo Yan China	8	119 0.5×	81 0.4×	136 0.6×	186 1.0×	41 0.3×	11	500
Matthew A. Powers United States	11	137 0.5×	240 1.1×	36 0.2×	163 0.8×	73 0.5×	21	615
Dan Zekzer United States	11	548 2.1×	393 1.8×	45 0.2×	221 1.2×	140 1.0×	11	828
Dorota Iwaszkiewicz‐Grześ Poland	12	264 1.0×	91 0.4×	101 0.5×	60 0.3×	43 0.3×	21	465
Suzanne M. Breckenridge United States	7	92 0.4×	46 0.2×	100 0.5×	90 0.5×	88 0.7×	8	366
Simone Giacometti United States	6	80 0.3×	240 1.1×	46 0.2×	449 2.3×	191 1.4×	6	644
Ivan H. Chan United States	10	393 1.5×	78 0.3×	362 1.7×	21 0.1×	154 1.1×	28	711
Isabelle Serr Germany	9	169 0.7×	142 0.6×	31 0.1×	111 0.6×	66 0.5×	13	349
Irina Proekt United States	8	313 1.2×	58 0.3×	63 0.3×	39 0.2×	141 1.0×	13	528

Countries citing papers authored by Adam L. Burrack

Since Specialization

Citations

This map shows the geographic impact of Adam L. Burrack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam L. Burrack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam L. Burrack more than expected).

Fields of papers citing papers by Adam L. Burrack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam L. Burrack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam L. Burrack. The network helps show where Adam L. Burrack may publish in the future.

Co-authorship network of co-authors of Adam L. Burrack

This figure shows the co-authorship network connecting the top 25 collaborators of Adam L. Burrack. A scholar is included among the top collaborators of Adam L. Burrack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam L. Burrack. Adam L. Burrack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Schmiechen, Zoe C., Adam L. Burrack, Nicholas J. Maurice, et al.. (2025). IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma. Cancer Immunology Research. 13(6). 847–866. 2 indexed citations

Patterson, Michael T., Adam L. Burrack, Yingzheng Xu, et al.. (2023). Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinoma. Cell Reports. 42(7). 112732–112732. 24 indexed citations

Spartz, Ellen J., Walker S. Lahr, Yun You, et al.. (2023). Germline T cell receptor exchange results in physiological T cell development and function. Nature Communications. 14(1). 528–528. 2 indexed citations

Sackett, Sara Dutton, Samuel J. Kaplan, Matthew E. Brown, et al.. (2022). Genetic Engineering of Immune Evasive Stem Cell-Derived Islets. Transplant International. 35. 10817–10817. 21 indexed citations

Burrack, Adam L., Ellen J. Spartz, Maria Firulyova, et al.. (2022). Cxcr3 constrains pancreatic cancer dissemination through instructing T cell fate. Cancer Immunology Immunotherapy. 72(6). 1461–1478. 7 indexed citations

Burrack, Adam L., Zoe C. Schmiechen, Michael T. Patterson, et al.. (2022). Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer. JCI Insight. 7(7). 11 indexed citations

Stromnes, Ingunn M., Ayaka Hulbert, Ryan Basom, et al.. (2022). Insufficiency of compound immune checkpoint blockade to overcome engineered T cell exhaustion in pancreatic cancer. Journal for ImmunoTherapy of Cancer. 10(2). e003525–e003525. 10 indexed citations

Burrack, Adam L., Ellen J. Spartz, Zoe C. Schmiechen, et al.. (2021). CD40 Agonist Overcomes T Cell Exhaustion Induced by Chronic Myeloid Cell IL-27 Production in a Pancreatic Cancer Preclinical Model. The Journal of Immunology. 206(6). 1372–1384. 20 indexed citations

Stromnes, Ingunn M., Adam L. Burrack, Ayaka Hulbert, et al.. (2019). Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma. Cancer Immunology Research. 7(6). 977–989. 52 indexed citations

10.

Burrack, Adam L., et al.. (2019). Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma. Cell Reports. 28(8). 2140–2155.e6. 64 indexed citations

11.

Osum, Kevin C., Adam L. Burrack, Tijana Martinov, et al.. (2018). Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes. Scientific Reports. 8(1). 114 indexed citations

12.

Spanier, Justin A., Joseph Wilson, Tijana Martinov, et al.. (2017). Increased Effector Memory Insulin-Specific CD4+ T Cells Correlate With Insulin Autoantibodies in Patients With Recent-Onset Type 1 Diabetes. Diabetes. 66(12). 3051–3060. 38 indexed citations

13.

Burrack, Adam L., Deepali Malhotra, Thamotharampillai Dileepan, et al.. (2017). Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides. The Journal of Immunology. 200(2). 477–482. 3 indexed citations

14.

Burrack, Adam L., Tijana Martinov, & Brian T. Fife. (2017). T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes. Frontiers in Endocrinology. 8. 343–343. 229 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact